Tris Pharma Receives FDA Approval of Dyanavel XR (amphetamine) Once-Daily Liquid for ADHD in Children ("Tris") announced that the U.S....
Read moreThe U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small...
Read moreTakeda Pharmaceutical Company Limited (TSE: 4502) announced that it will highlight the ixazomib clinical development program during multiple poster sessions...
Read moreOur focus is on enrolling patients in clinical trials to obtain the data required to enable regulatory and reimbursement authorities...
Read moreAlcon conducts clinical trials to evaluate the safety and efficacy of our products. These clinical studies are fundamental to driving...
Read moreAllergan plc (NYSE: AGN), a leading global specialty pharmaceutical company, today announced a multi-year research collaboration with Humana Inc. (NYSE:...
Read moreWe were pioneers among Indian pharmaceutical companies to see tremendous value in investing in research & development (R&D). Our early...
Read moreIn addition to ensuring that Amgen's investment decisions are based on compelling science, we are reengineering our processes to operate...
Read moreAt Amgen, we believe drug discovery starts with a deep understanding of biology. This understanding guides the critical choice of...
Read moreAt a time when technological breakthroughs are revolutionizing how drugs are discovered, Amgen's strategy aims to fully exploit the emerging...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
